文献速递心境障碍

昼夜节律稳定应用预防心境障碍复发:多中心双盲假对照随机临床试验

Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial.
PubMed 文献 · Am J Psychiatry · 2026-06-24

该多中心双盲随机对照试验将93名MDD或BD成人按1:1分配至活性CRM应用组或假应用组,干预12个月。改良意向治疗样本(N=80)中,假组复发率显著高于活性CRM组(IRR=3.39,95%CI=1.86-6.17),活性CRM延长复发时间并减少人均年复发天数,未见显著不良反应。

要点

  • CRM应用基于被动传感器数据提供个体化昼夜节律稳定反馈和3天情绪预测。
  • 假组复发率是活性CRM组的3.39倍(95%CI=1.86-6.17)。
  • 活性CRM组复发时间显著延长(HR=3.03,95%CI=1.58-5.81),未见显著不良反应。

核心结论

  • 昼夜节律稳定应用显著降低MDD和BD患者的复发率并改善临床病程。
  • CRM有望作为可扩展的数字时间治疗辅助手段整合到标准治疗中。

研究设计与样本

  • 多中心、双盲、假对照随机临床试验,93名MDD或BD成人按1:1分配至活性CRM组(N=47)或假应用组(N=46),干预12个月。
  • 主要结局为随访期间每名参与者的复发性心境发作次数,改良意向治疗样本N=80(活性CRM组N=38,假组N=42)。

主要发现

  • 假组复发率显著高于活性CRM组(IRR=3.39,95%CI=1.86-6.17)。
  • 假组人均年累积复发发作天数更多(持续时间率比=2.76,95%CI=1.19-6.40)。
  • 活性CRM组复发时间更优(HR=3.03,95%CI=1.58-5.81)。
  • 未观察到显著不良反应。

关键数值与推荐

  • 活性CRM组接受机器学习生成的个体化昼夜节律稳定反馈。
  • 假应用组接受由虚拟算法生成的非可操作反馈,界面视觉相同,设计为不影响昼夜节律行为。

临床怎么用

  • CRM可作为MDD和BD标准治疗的数字化时间治疗辅助工具,用于预防心境发作复发。
  • 应用通过被动传感器数据和机器学习提供个体化昼夜节律反馈及3天情绪预测。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preventing recurrence is essential for improving the clinical course of major depressive disorder (MDD) and bipolar disorder (BD). The authors developed the Circadian Rhythm for Mood (CRM) smartphone app, which provides individualized 3-day mood forecasts and delivers personalized circadian rhythm feedback using passive sensor data. This study tested the therapeutic efficacy of CRM in preventing mood episode recurrence compared with a sham app. METHODS: In a multicenter, double-blind, randomized clinical trial, 93 adults with MDD or BD were assigned in a 1:1 ratio to active CRM (N=47) or a sham app (N=46) for 12 months. Participants in the active CRM group received personalized circadian rhythm stabilization feedback generated by machine learning. Participants in the sham app group received nonactionable feedback from a dummy algorithm, designed not to influence circadian behavior, with a visually identical interface. The primary outcome was the number of recurrent mood episodes per participant during follow-up. RESULTS: In the modified intention-to-treat sample (N=80), the sham group (N=42) had a significantly higher recurrence rate than the active CRM group (N=38) (incidence rate ratio=3.39, 95% CI=1.86-6.17). Cumulative recurrent episode-days per person-year were greater in sham group (duration rate ratio=2.76, 95% CI=1.19-6.40), and time to recurrence favored active CRM (hazard ratio=3.03, 95% CI=1.58-5.81). No significant adverse effects were observed. CONCLUSIONS: The circadian rhythm stabilization app significantly reduced recurrence and improved the clinical course in MDD and BD. CRM has potential as an innovative, scalable digital chronotherapeutic adjunct to standard care.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Yeom JW, Jeong J, Moon E, et al. Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial. Am J Psychiatry. 2026. PMID: 42337416. doi:10.1176/appi.ajp.20251008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。